German study tracks Real-Life impact of MS pill on Patients' lives
NCT ID NCT05335031
Summary
This study observed 450 people with relapsing multiple sclerosis in Germany who were already prescribed ozanimod (Zeposia) by their doctor. Over three years, it tracked how long patients stayed on the medication, how well it controlled their MS symptoms, and how it affected their daily life and quality of life. The goal was to understand the real-world benefits and side effects of this treatment outside of a controlled clinical trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS, RELAPSING-REMITTING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Universitätsklinikum Dresden, MS Ambulanz
Dresden, Saxony, 01307, Germany
Conditions
Explore the condition pages connected to this study.